Journal article

Csk-homologous kinase (Chk) is an efficient inhibitor of Src-family kinases but a poor catalyst of phosphorylation of their C-terminal regulatory tyrosine

G Advani, YC Lim, B Catimel, DSS Lio, NLY Ng, AC Chüeh, M Tran, MI Anasir, H Verkade, HJ Zhu, BE Turk, TE Smithgall, CS Ang, M Griffin, HC Cheng

Cell Communication and Signaling | BIOMED CENTRAL LTD | Published : 2017

Abstract

Background: C-terminal Src kinase (Csk) and Csk-homologous kinase (Chk) are the major endogenous inhibitors of Src-family kinases (SFKs). They employ two mechanisms to inhibit SFKs. First, they phosphorylate the C-terminal tail tyrosine which stabilizes SFKs in a closed inactive conformation by engaging the SH2 domain in cis. Second, they employ a non-catalytic inhibitory mechanism involving direct binding of Csk and Chk to the active forms of SFKs that is independent of phosphorylation of their C-terminal tail. Csk and Chk are co-expressed in many cell types. Contributions of the two mechanisms towards the inhibitory activity of Csk and Chk are not fully clear. Furthermore, the determinants..

View full abstract